Houston biotech firm Coya Therapeutics files for IPO

About two years after its launch, Coya Therapeutics is going public. The Houston firm specializes in cell therapies targeting neurodegenerative diseases.

Hutto highlights slew of major economic development projects potentially headed to city

The FTC is aiming to block Meta from profiting off young people’s data

Durham hotel sold, will be converted to affordable housing

Founder steps down from Houston’s biggest health care PE firm

Cincinnati Children’s Hospital’s Rothenberg named to National Academy of Medicine

Johns Hopkins Medicine may terminate contract with CareFirst

Best Real Estate Projects 2023: UC Davis Health Ernest E. Tschannen Eye Institute

Why a NYC developer is building a high-end subdivision upstate

Houston biotech firm Coya Therapeutics files for IPO

Previous 2 Missouri hospitals recognized in national ranking

Next Inno Fire Awards honoree: SweetBio and co-founder Kayla Rodriguez Graff

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Rob Lowe bringing one man show to Dayton this summer

Campbell Soup to sell Bolthouse Farms for $510M

Jonathan’s Grille eyes Birmingham, plans Huntsville location

Value-based care is key to increasing health care quality in Florida

Calvert Street Capital’s diversity fellowship aims to bring new perspectives to investment management

Startups race to pad coffers before funding drys up

MENU

FirstStar Group

More Stories

SA LGBT Chamber of Commerce president talks Pride Month and impact on business community

Previous 2 Missouri hospitals recognized in national ranking

Next Inno Fire Awards honoree: SweetBio and co-founder Kayla Rodriguez Graff

firststargroup

Related Posts

Suggested Posts

MENU

FirstStar Group

More Stories